At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living
In Brief
A clinical study evaluating Shed-MEDS deprescribing intervention for Polypharmacy and 2 related conditions. Completed, enrolled 18 participants across 2 sites.
Detailed Summary
This single-arm pilot study will evaluate the effects of an intervention to reduce exposure to unnecessary or potentially harmful medications among residents with dementia living in an assisted living facility. The goal of the intervention is to safely deprescribe medications (defined by dose reductions and stopped medications), based on a combination of clinical criteria and resident/surrogate preferences. The investigators will evaluate the effects of the intervention on the total number of medications deprescribed from enrollment at 30, 60, and 90 days along with resident/surrogate reports of quality of life at enrollment and 90 days.
Study Details
Timeline
Interventions
See single arm description